ATE71149T1 - Monoklonale antikoerper. - Google Patents

Monoklonale antikoerper.

Info

Publication number
ATE71149T1
ATE71149T1 AT85302806T AT85302806T ATE71149T1 AT E71149 T1 ATE71149 T1 AT E71149T1 AT 85302806 T AT85302806 T AT 85302806T AT 85302806 T AT85302806 T AT 85302806T AT E71149 T1 ATE71149 T1 AT E71149T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
vitro
cells
lysing
complement
Prior art date
Application number
AT85302806T
Other languages
English (en)
Inventor
Thierry Hercend
Jerome Ritz
Stuart F Schlossman
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE71149T1 publication Critical patent/ATE71149T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT85302806T 1984-04-23 1985-04-22 Monoklonale antikoerper. ATE71149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/603,181 US4772552A (en) 1984-04-23 1984-04-23 Monoclonal antibody which recognizes a 200-220 KD antigen on natural killer cells
EP85302806A EP0160486B1 (de) 1984-04-23 1985-04-22 Monoklonale Antikörper

Publications (1)

Publication Number Publication Date
ATE71149T1 true ATE71149T1 (de) 1992-01-15

Family

ID=24414404

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85302806T ATE71149T1 (de) 1984-04-23 1985-04-22 Monoklonale antikoerper.

Country Status (6)

Country Link
US (1) US4772552A (de)
EP (1) EP0160486B1 (de)
JP (2) JPS6128000A (de)
AT (1) ATE71149T1 (de)
CA (1) CA1271715A (de)
DE (1) DE3585049D1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028424A (en) * 1987-10-16 1991-07-02 University Of Georgia Research Foundation Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells
US4895796A (en) * 1988-01-06 1990-01-23 Becton Dickinson And Company Identification of NK cells and cytotoxic T lymphocytes
DK172110B1 (da) 1988-04-15 1997-10-27 Gen Hospital Corp Fremgangsmåde til isolation af mutanter af DNA-sekvenser og anvendelsen heraf til identifikation af celleoverfladeproteiner
US5089384A (en) * 1988-11-04 1992-02-18 Amoco Corporation Method and apparatus for selective cell destruction using amplified immunofluorescence
PT621786E (pt) 1992-01-08 2002-07-31 Gen Hospital Corp Inducao da tolerancia a xenoenxertos
US5658564A (en) * 1992-02-19 1997-08-19 The General Hospital Corporation Xenograft thymus
US5663481A (en) * 1993-08-06 1997-09-02 Mount Sinai Hospital Corporation Animal model of the human immune system
WO1995006247A1 (en) 1993-08-27 1995-03-02 Dana-Farber Cancer Institute, Inc. Natural killer cell-specific antigen and antibodies that identify the same
JP4294286B2 (ja) 2002-09-24 2009-07-08 富士重工業株式会社 車両の差動制限制御装置
WO2005105849A1 (en) * 2004-04-30 2005-11-10 Innate Pharma Compositions and methods for treating proliferative disorders such as nk-type ldgl

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4607007A (en) * 1983-04-07 1986-08-19 Becton, Dickinson And Company Differentiation of natural killer cell subpopulations of cells
US4599307A (en) * 1983-07-18 1986-07-08 Becton, Dickinson And Company Method for elimination of selected cell populations in analytic cytology
US4599304A (en) * 1983-10-07 1986-07-08 Becton, Dickinson And Company Method for monitoring activated cell subpopulations
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same

Also Published As

Publication number Publication date
DE3585049D1 (de) 1992-02-13
US4772552A (en) 1988-09-20
EP0160486A3 (en) 1987-06-16
JPH0734742B2 (ja) 1995-04-19
JPS6128000A (ja) 1986-02-07
EP0160486B1 (de) 1992-01-02
JPH0662845A (ja) 1994-03-08
JPH0588115B2 (de) 1993-12-21
CA1271715A (en) 1990-07-17
EP0160486A2 (de) 1985-11-06

Similar Documents

Publication Publication Date Title
ATE273386T1 (de) Menschliches cyclin e
DK69890D0 (da) Monoklonale antistoffer, der er reaktive med cachetin
DE3173597D1 (en) Specific antibody and its use in an enzyme immuno assay
WO1989003846A3 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
UA6035A1 (uk) Засіб для визначення лейкоцітів в сечі
AU3614384A (en) Anti-idiotype antibodies & their use in inducing immulogical response to viruses & tumours
ES8600404A1 (es) Un metodo para detectar una secuencia seleccionada de acido nucleico en un material biologico.
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
ATE59185T1 (de) Die antigenischen determinanten von hbxag.
ES8402346A1 (es) Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente.
ATE71149T1 (de) Monoklonale antikoerper.
FI830573A7 (fi) Syövän diagnoosissa ja hoidossa hyödylliset vasta-aineet ja antigeenit.
DE3477845D1 (en) Lewis blood group phenotype assay
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
DE3882727D1 (de) Mycoplasma-membran-antigene und ihre verwendung.
EP0131627A4 (de) Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikörper und verfahren zu ihrer verwendung.
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
DE3587714D1 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
IT7926556A0 (it) Trasportatore autocentrante, in particolare per legatorie e simili.
ATE40216T1 (de) Monoklonaler antikoerper.
NO862920L (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
SE468853B (sv) Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time